Device Endotherapy

Endoclot Phs

Payments companies reported to CMS as associated with Endoclot Phs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$90Kassociated payments (2023-2025)
900clinicians with associated payments
3companies reporting

By year

2023 $45K
2024 $22K
2025 $23K

Payments reported as associated with Endoclot Phs, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $79K
Internal Medicine $2,109
Surgery $1,527
Family $1,299
Nurse Anesthetist, Certified Registered $908
Hospitalist $603

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Endoclot Phs

These are the largest totals companies reported as associated with Endoclot Phs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ahmed Saeed Kansas City, MO Gastroenterology (Internal Medicine) $14,205.73
Saowanee Ngamruengphong Baltimore, MD Gastroenterology (Internal Medicine) $9,621.40
Peter Draganov Gainesville, FL Gastroenterology (Internal Medicine) $4,771.14
Gregory Haber New York, NY Gastroenterology (Internal Medicine) $3,949.76
Mihir Wagh Aurora, CO Gastroenterology (Internal Medicine) $3,471.04
Yana Cavanagh Paterson, NJ Gastroenterology (Internal Medicine) $3,341.32
Dennis Yang Orlando, FL Gastroenterology (Internal Medicine) $1,736.84
Ashley Vareedayah Chicago, IL Gastroenterology (Internal Medicine) $922.76
Sandeep Patel San Antonio, TX Gastroenterology (Internal Medicine) $639.74
Courtney Ferch Grand Rapids, MI Gastroenterology (Internal Medicine) $639.71

Prescribed Endoclot Phs?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.